Key takeaways
- Leukemia is also known as the cancer of the blood.
- In 2020 over, 490,000 people were diagnosed with leukemia in the United States.
- Research shows that CBD may improve symptoms of leukemia such as pain, and limit the spread of cancer cells.
- Research shows that CBD may attack cancerous cells without harming normal cells.
CBD and cancer are emerging aspects of CBD medicines that have caught the attention of many people. Over the years, the role of CBD in breast and prostate cancer has sparked considerable interest among individuals living with cancer. The fact that CBD can reduce the side effects of chemotherapy is an added advantage. In this article, we will discuss the potential roles of CBD in improving leukemia symptoms.
Overview of Leukemia
Leukemia is a type of cancer that affects the blood and bone marrow, characterized by an abnormal increase in the number of white blood cells, particularly immature or abnormal ones. These cells, known as leukemia cells, interfere with the normal production of red blood cells, platelets, and healthy white blood cells. This disruption can lead to various health problems.
There are four main types of leukemia: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). The classification is based on the type of white blood cell affected and the speed of disease progression.
According to information from the National Cancer Institute, in 2020, an estimated 490,875 people were living with leukemia in the United States. Early diagnosis and appropriate medical intervention are crucial for improving outcomes in individuals with leukemia.
Common symptoms of Leukemia
- Fatigue
- Weakness
- Frequent infections
- Easy bruising or bleeding
- Swollen lymph nodes
- Weight loss.
How May CBD help people with Leukemia?
People who use CBD oil have reported its potential benefits for addressing various health issues, including anxiety, insomnia, reduced appetite, pain, and fatigue. Individuals dealing with leukemia often experience these symptoms, impacting their overall well-being through disrupted sleep, persistent discomfort, and undesired weight loss.
Before incorporating CBD products into your routine for managing cancer symptoms or treatment side effects, it's essential to consult with an expert who will guide you on the right product choice, mode of administration and dosage. Here are some of the possible potential therapeutic benefits of CBD for leukemia.
Improving sleep quality
CBD may promote sleep by interacting with receptors in the endocannabinoid system, influencing factors like anxiety and stress that contribute to sleep disturbances. Individuals with leukemia, often battling with insomnia due to the emotional toll and treatment side effects, may find relief with CBD. Several people have reported positive experiences, citing CBD's calming effects. While research on CBD and sleep is ongoing, early findings suggest its potential to enhance sleep quality. It's crucial for those with leukemia to consult with an expert before incorporating CBD, ensuring its compatibility with their treatment plan and overall health. Personalized guidance can optimize potential benefits while considering individual medical considerations.
Managing Pain with CBD
Some individuals turn to CBD oil as an alternative to stronger chronic pain medications or for supplementary relief. Research, including a 2017 meta-analysis of 24 randomized controlled trials, suggests that cannabis-based medicines may aid in alleviating neuropathic pain. Health care professionals are exploring the potential for CBD formulations to replace opioids in chronic pain management, though more research is needed. Studies indicate that activating cannabinoid receptors may enhance the pain-relieving effects of nonsteroidal anti-inflammatory drugs (NSAIDs).
Addressing Nausea and Appetite Stimulation
CBD and other cannabinoids have been utilized since the 1980s for appetite stimulation and managing nausea. CBD's potential role in addressing nausea and stimulating appetite can be of particular interest to individuals dealing with leukemia. A 2001 study reported how CBD had better effect on chemotherapy-induced nausea than other medications.
Additionally, CBD and other cannabinoids have been utilized for appetite stimulation. Leukemia and its treatments often lead to unwanted weight loss and reduced appetite. CBD may help manage these symptoms by interacting with the endocannabinoid system, influencing sensations of nausea and promoting a healthier appetite.
Anticancer properties
Researchers have explored CBD's potential anticancer effects in acute lymphoblastic leukemia treatment. Animal studies suggest that CBD can enter cells, potentially promoting targeted destruction of tumor cells. Notably, noncancerous cells exhibit resistance to CBD, indicating a selective impact on cancer cells with limited effects on healthy cells. It's essential to recognize that while CBD shows promise, it is not a substitute for conventional leukemia treatment.
How to use CBD for cancer?
Using CBD for cancer requires careful consideration and collaboration with healthcare professionals. Begin by consulting with your oncologist or an expert to discuss your specific situation. Clearly define your treatment goals, whether it's symptom management or complementary therapy. When choosing CBD products, prioritize quality from reputable sources with third-party testing. Select a suitable formulation, such as oil tinctures, capsules, or topicals, and start with a low dosage, gradually adjusting based on individual response. It's crucial to be aware of potential drug interactions, informing your healthcare provider about all medications. Monitor for side effects and stay in regular communication with your medical team to ensure CBD aligns with your overall cancer treatment plan. Remember, CBD is not a substitute for conventional cancer treatment, but it may offer supportive benefits when used responsibly and under professional guidance.
Frequently asked questions
How long does CBD stay in your system?
The duration that CBD remains in an individual's system varies, ranging from several hours to approximately a month. This timeframe is contingent on factors such as the dosage and administration method chosen by the individual. The half-life of CBD within the body spans from approximately 1 hour to a maximum of 5 days.
Is CBD effective against cancer?
Yes, research studies show CBD may limit the spread of cancerous cells this is however still subject to further research.
Is CBD safe for cancer?
Yes, unlike other forms of cancer treatment, pure CBD produces little to no adverse side effects on users making it safe for use.
Want to Learn More?
- What Is Ayurveda, And Is It For Me?
- Why Flavored CBD Is Low Quality
- Nesas Hemp—the first to receive the Exclusive Tested Safe Seal.
- Foods That Enhance CBDa
- How To Read A Certificate Of Analysis
Sources
Olivas-Aguirre M, Torres-López L, Valle-Reyes JS, Hernández-Cruz A, Pottosin I, Dobrovinskaya O. Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia. Cell Death Dis. 2019 Oct 14;10(10):779. doi: 10.1038/s41419-019-2024-0. PMID: 31611561; PMCID: PMC6791884.
Aviram J, Samuelly-Leichtag G. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pain Physician. 2017 Sep;20(6):E755-E796. PMID: 28934780.
Tramèr, M. R., Carroll, D., Campbell, F. A., M Reynolds, D. J., Moore, R. A., & McQuay, H. J. (2001). Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review. BMJ : British Medical Journal, 323(7303), 16. https://doi.org/10.1136/bmj.323.7303.16
Melén CM, Merrien M, Wasik AM, Panagiotidis G, Beck O, Sonnevi K, Junlén HR, Christensson B, Sander B, Wahlin BE. Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2022 Jun;63(6):1387-1397. doi: 10.1080/10428194.2021.2020776. Epub 2022 Jan 17. PMID: 35037561.
Maggi, F., Morelli, M. B., Tomassoni, D., Marinelli, O., Aguzzi, C., Zeppa, L., Nabissi, M., Santoni, G., & Amantini, C. (2022). The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib. Cancer Science, 113(4), 1235-1249. https://doi.org/10.1111/cas.15257
